Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
265.60
-1.41 (-0.53%)
May 28, 2026, 11:17 AM EDT - Market open
Cencora Revenue
Cencora had revenue of $78.36B in the quarter ending March 31, 2026, with 3.85% growth. This brings the company's revenue in the last twelve months to $328.68B, up 5.95% year-over-year. In the fiscal year ending September 30, 2025, Cencora had annual revenue of $321.33B with 9.31% growth.
Revenue (ttm)
$328.68B
Revenue Growth
+5.95%
P/S Ratio
0.16
Revenue / Employee
$6,444,706
Employees
51,000
Market Cap
51.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 321.33B | 27.37B | 9.31% |
| Sep 30, 2024 | 293.96B | 31.79B | 12.12% |
| Sep 30, 2023 | 262.17B | 23.59B | 9.89% |
| Sep 30, 2022 | 238.59B | 24.60B | 11.49% |
| Sep 30, 2021 | 213.99B | 24.10B | 12.69% |
| Sep 30, 2020 | 189.89B | 10.31B | 5.74% |
| Sep 30, 2019 | 179.59B | 11.65B | 6.94% |
| Sep 30, 2018 | 167.94B | 14.80B | 9.66% |
| Sep 30, 2017 | 153.14B | 6.29B | 4.29% |
| Sep 30, 2016 | 146.85B | 10.89B | 8.01% |
| Sep 30, 2015 | 135.96B | 16.39B | 13.71% |
| Sep 30, 2014 | 119.57B | 31.61B | 35.94% |
| Sep 30, 2013 | 87.96B | 9.88B | 12.65% |
| Sep 30, 2012 | 78.08B | -614.90M | -0.78% |
| Sep 30, 2011 | 78.70B | 919.20M | 1.18% |
| Sep 30, 2010 | 77.78B | 6.02B | 8.38% |
| Sep 30, 2009 | 71.76B | 1.57B | 2.24% |
| Sep 30, 2008 | 70.19B | 8.92B | 14.56% |
| Sep 30, 2007 | 61.27B | 454.40M | 0.75% |
| Sep 30, 2006 | 60.81B | 10.80B | 21.59% |
| Sep 30, 2005 | 50.01B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 403.43B |
| Cardinal Health | 250.74B |
| Henry Schein | 13.38B |
| Accendra Health | 2.72B |
| 111, Inc. | 1.80B |
| EDAP TMS | 74.07M |
| Cosmos Health | 69.49M |
| Synergy CHC | 27.70M |
COR News
- 1 day ago - Cencora appoints Eva Boratto as CFO - TheFly
- 1 day ago - Cencora backs FY26 adjusted EPS view $17.70-$17.90, consensus $17.75 - TheFly
- 1 day ago - Cencora still sees long-term adjusted EPS growth of 10%-14% - TheFly
- 1 day ago - Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer - Business Wire
- 6 days ago - Cencora revises forecast for 2026, approves $2 billion share buyback - Reuters
- 6 days ago - Cencora narrows FY26 adjusted EPS view to $17.70-$17.90, consensus $17.76 - TheFly
- 6 days ago - Cencora Announces Updated Fiscal Year 2026 Financial Outlook - Business Wire
- 15 days ago - Cencora Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts